首页> 外文期刊>Endoscopy: Journal for Clinical Use Biopsy and Technique >Systematic review of endoscopic mucosal resection versus transanal endoscopic microsurgery for large rectal adenomas.
【24h】

Systematic review of endoscopic mucosal resection versus transanal endoscopic microsurgery for large rectal adenomas.

机译:内镜黏膜切除术与经肛门内镜显微手术对大直肠腺瘤的系统评价。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND STUDY AIMS: Large ( > 2 cm) rectal adenomas are currently treated by either transanal endoscopic microsurgery (TEM) or piecemeal endoscopic mucosal resection (EMR). The potential lower morbidity of EMR may become irrelevant if EMR is less effective. The aim of this study was to compare the safety and effectiveness of EMR and TEM for large rectal adenomas. PATIENTS AND METHODS: A systematic review of the literature published between January 1980 and January 2009 was conducted. Pooled estimates of the proportion of patients with recurrence or complications in EMR and TEM studies were compared using random effects meta-regression analysis. Early (after single intervention) and late (excluding re-treatment of residual adenoma detected within 3 months) recurrence rates were calculated. RESULTS: A total of 20 EMR studies and 48 TEM studies were included. No studies directly compared EMR with TEM. Mean polyp size was 31 mm (range 2 - 86 mm) for EMR vs. 37 mm (range 3 - 182 mm) for TEM (P = 0.02). Early recurrence rates were 11.2 % (95 % confidence interval [CI] 6.0 - 19.9) for EMR vs. 5.4 % (95 %CI 4.0 - 7.3) for TEM (P = 0.04). Late recurrence rates were 1.5 % (95 %CI 0.6 - 3.9) for EMR vs. 3.0 % (95 %CI 1.3 - 6.9) for TEM (P = 0.29). Postoperative complication rates were 3.8 % (95 %CI 2.8 - 5.3) for EMR vs. 13.0 % (95 %CI 9.8 - 17.0) for TEM (P < 0.001). CONCLUSIONS: After single intervention, EMR for large rectal adenomas appears to be less effective but safer than TEM. When outcome data for re-treatment of residual adenoma within 3 months are included, EMR and TEM seem equally effective. Nevertheless, the added morbidity of additional EMRs could not be accounted for in this analysis. A prospective randomized trial seems imperative before making recommendations concerning the treatment of large rectal adenomas.
机译:背景和研究目的:大的(> 2 cm)直肠腺瘤目前通过经肛门内窥镜显微手术(TEM)或经内镜黏膜切除术(EMR)进行治疗。如果EMR的疗效较差,则EMR潜在的较低发病率可能变得无关紧要。这项研究的目的是比较EMR和TEM对大直肠腺瘤的安全性和有效性。病人与方法:对1980年1月至2009年1月间发表的文献进行了系统的综述。使用随机效应荟萃回归分析比较了EMR和TEM研究中复发或并发症患者比例的合并估计值。计算早期(单次干预后)和晚期(不包括3个月内发现的残留腺瘤的再治疗)复发率。结果:总共包括20项EMR研​​究和48项TEM研究。没有研究直接将EMR与TEM进行比较。 EMR的平均息肉大小为31毫米(范围2-86毫米),而TEM的平均息肉大小为37毫米(范围3-182毫米)(P = 0.02)。 EMR的早期复发率为11.2%(95%置信区间[CI] 6.0-19.9),而TEM为5.4%(95%CI 4.0-7.3)(P = 0.04)。 EMR的晚期复发率为1.5%(95%CI 0.6-3.9),而TEM为3.0%(95%CI 1.3-6.9)(P = 0.29)。 EMR的术后并发症发生率为3.8%(95%CI 2.8-5.3),而TEM的为13.0%(95%CI 9.8-17.0)(P <0.001)。结论:单次干预后,EMR治疗大直肠腺瘤似乎不如TEM有效,但更安全。如果包括3个月内残留腺瘤再治疗的结局数据,则EMR和TEM似乎同样有效。但是,在此分析中无法解释其他EMR的增加发病率。在就大直肠腺瘤的治疗提出建议之前,一项前瞻性随机试验似乎势在必行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号